Genentech Inc - Company Profile
Powered by 
All the sales intelligence you need on Genentech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Genentech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Genentech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Genentech Catalyst Calendar
Proactively evaluate Genentech Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Genentech Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 06 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 04 Sep 2019 | Regulatory Approval (EU) | Genentech USA Inc | - | polatuzumab vedotin | Oncology | Diffuse Large B-Cell Lymphoma | GD Estimates |
| 01 Sep 2019 | Phase II Trial Initiation | Fox Chase Cancer Center; Genentech USA Inc; National Comprehensive Cancer Network | - | atezolizumab | Oncology | Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma | Clinical Trial Registry |
| 01 Sep 2019 | Phase II Trial Initiation | F. Hoffmann-La Roche Ltd; Genentech USA Inc; Infinity Pharmaceuticals Inc | INFI; ROG | atezolizumab; bevacizumab; eganelisib | Oncology | Breast Cancer; Metastatic Renal Cell Carcinoma; Renal Cell Carcinoma; Triple-Negative Breast Cancer (TNBC) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer